Altesa BioSciences

College Park, GA · Founded 2020 · Privately Held (backing)

Developer of antiviral medicines designed for the treatment of respiratory infections and global viral threats. Altesa BioSciences is based in College Park, GA and was founded in 2020. It was valued at $190 million at its later-stage round in Feb 2026, the last priced event on record. It has raised $114 million across 2 recorded rounds; the latest was a $75 million later-stage round in Feb 2026.

PMV mark · valuation
$190.0M
Oct 2026
Priced at
its later-stage round
Feb 2026
Total raised
$114.0M
Last round
Later Stage VC
Feb 2026

Who backs Altesa BioSciences?

7 investors
InvestorType
Pitango Venture CapitalVenture capital
ForbionVenture capital
Atlantic Partners—
GRA Venture Fund—
Medicxi—
National Institute for Allergy and Infectious Disease—
Sanofi—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Altesa BioSciences investors

7 investors are on record for Altesa BioSciences, including Pitango Venture Capital, Forbion, Atlantic Partners and GRA Venture Fund. The later-stage round in Feb 2026 drew 17 investors.

Free account
More of Altesa BioSciences with a free account
  • ·Watch Altesa BioSciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 7 firms already write checks for companies like Altesa BioSciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View